<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     naa a22        4500</leader>
  <controlfield tag="001">510763979</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180411083149.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">180411e20130401xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s12094-012-0914-z</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s12094-012-0914-z</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Tumor volume delineation in head and neck cancer with 18-fluor-fluorodeoxiglucose positron emission tomography: adaptive thresholding method applied to primary tumors and metastatic lymph nodes</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Luis Perez-Romasanta, Maria Bellon-Guardia, Javier Torres-Donaire, Eva Lozano-Martin, Miguel Sanz-Martin, Joaquin Velasco-Jimenez]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Purpose: There are several potential advantages of using 18-fluor-fluorodeoxiglucose (18F-FDG) PET for target volume contouring, but before PET-based gross tumor volumes (GTVs) can reliably and reproducibly be incorporated into high-precision radiotherapy planning, operator-independent segmentation tools have to be developed and validated. The purpose of the present work was to apply the adaptive to the signal/background ratio (RS/B) thresholding method for head and neck tumor delineation, and compare these GTVPET to reference GTVCT volumes in order to assess discrepancies. Materials and methods: A cohort of 19 patients (39 lesions) with a histological diagnosis of head and neck cancer who would undergo definitive concurrent radiochemotherapy or radical radiotherapy with intensity-modulated radiotherapy technique (IMRT), were enrolled in this prospective study. Contouring on PET images was accomplished through standardized uptake value (SUV)-threshold definition. The threshold value was adapted to RS/B. To determine the relationship between the threshold and the RS/B, we performed a phantom study. A discrepancy index (DI) between both imaging modalities, overlap fraction (OF) and mismatch fraction (MF) were calculated for each lesion and imaging modality. Results: The median DI value for lymph nodes was 2.67 and 1.76 for primary lesions. The OF values were larger for CT volumes than for PET volumes (p&lt;0.001), for both types of lesions. The MF values were smaller for CT volumes than for PET volumes (p&lt;0.001), for both types of lesions. The GTVPET coverage (OFPET) was strongly correlated with the lesion volume (GTVCT) for metastatic lymph nodes (Pearson correlation=0.665; p&lt;0.01). For smaller lesions, despite the GTV volumes were relatively larger on PET than in CT contours, the coverage was poorer. Accordingly, the MFPET/CT was negatively correlated with the lesion volume for metastatic lymph nodes. Conclusions: The present study highlights the considerable challenges involved in using FDG PET imaging for the delineation of GTV in head and neck neoplasms. The methods that rely mainly on SUVmax for thresholding, as the RS/B method, are very sensitive to partial volume effects and may provide unreliable results when applied on small lesions.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Federación de Sociedades Españolas de Oncología (FESEO), 2012</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Head and neck cancer</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">18F-FDG PET/CT</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Radiotherapy planning</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Target volume</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Perez-Romasanta</subfield>
   <subfield code="D">Luis</subfield>
   <subfield code="u">Radiation Oncology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Bellon-Guardia</subfield>
   <subfield code="D">Maria</subfield>
   <subfield code="u">Nuclear Medicine, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Torres-Donaire</subfield>
   <subfield code="D">Javier</subfield>
   <subfield code="u">Radiation Physics, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Lozano-Martin</subfield>
   <subfield code="D">Eva</subfield>
   <subfield code="u">Radiation Oncology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Sanz-Martin</subfield>
   <subfield code="D">Miguel</subfield>
   <subfield code="u">Radiation Oncology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Velasco-Jimenez</subfield>
   <subfield code="D">Joaquin</subfield>
   <subfield code="u">Radiation Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Clinical and Translational Oncology</subfield>
   <subfield code="d">Springer Milan</subfield>
   <subfield code="g">15/4(2013-04-01), 283-293</subfield>
   <subfield code="x">1699-048X</subfield>
   <subfield code="q">15:4&lt;283</subfield>
   <subfield code="1">2013</subfield>
   <subfield code="2">15</subfield>
   <subfield code="o">12094</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s12094-012-0914-z</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s12094-012-0914-z</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Perez-Romasanta</subfield>
   <subfield code="D">Luis</subfield>
   <subfield code="u">Radiation Oncology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Bellon-Guardia</subfield>
   <subfield code="D">Maria</subfield>
   <subfield code="u">Nuclear Medicine, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Torres-Donaire</subfield>
   <subfield code="D">Javier</subfield>
   <subfield code="u">Radiation Physics, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Lozano-Martin</subfield>
   <subfield code="D">Eva</subfield>
   <subfield code="u">Radiation Oncology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Sanz-Martin</subfield>
   <subfield code="D">Miguel</subfield>
   <subfield code="u">Radiation Oncology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Velasco-Jimenez</subfield>
   <subfield code="D">Joaquin</subfield>
   <subfield code="u">Radiation Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Clinical and Translational Oncology</subfield>
   <subfield code="d">Springer Milan</subfield>
   <subfield code="g">15/4(2013-04-01), 283-293</subfield>
   <subfield code="x">1699-048X</subfield>
   <subfield code="q">15:4&lt;283</subfield>
   <subfield code="1">2013</subfield>
   <subfield code="2">15</subfield>
   <subfield code="o">12094</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
